Skip to content

Prestige Consumer Healthcare PBH North American OTC Healthcare — Total revenues

Other segment segments

International OTC Healthcare
$47.07M-1.0%

Similar metrics at other companies

Bausch + Lomb logo
BLCOOTC — Total revenues
$444M+8.6%
McKesson logo
MCKNorth American Pharmaceutical — Total revenues
$79.12B+2.8%
Weatherford International logo
WFRDNorth America — Total Revenue
$220M-12.0%
Mirion Technologies logo
MIRNorth America — Total revenues
$175M+33.9%
Americold Realty Trust logo
COLDNorth America — Total revenues
$478.1M-5.0%
Life360, Inc. logo
LIFNorth America — Total Revenue
$125.62M+37.5%

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.18B-34.1%
Enterprise value$3.16B-27.3%
P/E11.5×-4.0×
P/S-0.9×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's north american otc healthcare — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's north american OTC healthcare — total revenues?
Prestige Consumer Healthcare (PBH) reported north american OTC healthcare — total revenues of $234.55M in Q1 2026.
How has Prestige Consumer Healthcare's north american OTC healthcare — total revenues changed year-over-year?
Prestige Consumer Healthcare's north american OTC healthcare — total revenues decreased by 5.8% year-over-year, from $248.95M to $234.55M.
What is the long-term trend for Prestige Consumer Healthcare's north american OTC healthcare — total revenues?
Over 4 years (2022 to 2026), Prestige Consumer Healthcare's north american OTC healthcare — total revenues has grown at a -1.4% compound annual growth rate (CAGR), from $967.88M to $913.58M.
What does north american OTC healthcare — total revenues mean?
The total gross income generated by the North American OTC healthcare segment from the sale of over-the-counter products to customers. This is a primary indicator of the segment's market demand, pricing power, and overall scale within the consumer healthcare industry.